ConductScience.org, home

Paper39355646

Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study.

Naja K and 3 others. J Pharm Pharm Sci, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study. Papers, record 39355646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39355646

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study.
PubMed
Journal
J Pharm Pharm Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.2, provisional
iCite
Revised in PubMed
2026-09-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Naja KKhaled
2Anwardeen NNajeha
3Bashraheel SSSara S
4Elrayess MAMohamed A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Sulfonylurea CompoundsMajor topic
Hypoglycemic AgentsMajor topic
MetabolomicsMajor topic
Humans
Cross-Sectional Studies
Male
Female
Middle Aged
Aged
Glycated Hemoglobin

Source PubMed

Download CSV of topics

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129305667A pilot study comparing the metabolic profiles of elite-level athletes from different sporting disciplines.Sports Med Open2018https://conductscience.org/library/papers/29305667PubMed
221186350Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.Nat Genet2011https://conductscience.org/library/papers/21186350PubMed
335727887Comprehensive Review of γ-Glutamyl Peptides (γ-GPs) and Their Effect on Inflammation Concerning Cardiovascular Health.J Agric Food Chem2022https://conductscience.org/library/papers/35727887PubMed
431536110Sulfonylureas and Cardiovascular Safety: The Final Verdict?JAMA2019https://conductscience.org/library/papers/31536110PubMed
536543979Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis.Nat Cell Biol2023https://conductscience.org/library/papers/36543979PubMed
633589583Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors.Transl Psychiatry2021https://conductscience.org/library/papers/33589583PubMed
728611053The rs7903146 Variant in the TCF7L2 Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity.Diabetes Care2017https://conductscience.org/library/papers/28611053PubMed
832572055Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease.Sci Rep2020https://conductscience.org/library/papers/32572055PubMed
932059521Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System.Biomolecules2020https://conductscience.org/library/papers/32059521PubMed
1037429905The metabolomic profiling of total fat and fat distribution in a multi-cohort study of women and men.Sci Rep2023https://conductscience.org/library/papers/37429905PubMed
1137626661Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study.Biomedicines2023https://conductscience.org/library/papers/37626661PubMed
1226237395Roles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity.J Clin Med2014https://conductscience.org/library/papers/26237395PubMed
1331958027Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.Expert Rev Clin Pharmacol2020https://conductscience.org/library/papers/31958027PubMed
1428380376SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion.Cell Metab2017https://conductscience.org/library/papers/28380376PubMed
1535053251Multi-Organ Crosstalk with Endocrine Pancreas: A Focus on How Gut Microbiota Shapes Pancreatic Beta-Cells.Biomolecules2022https://conductscience.org/library/papers/35053251PubMed
1624563333Sulfonylureas: a new look at old therapy.Curr Diab Rep2014https://conductscience.org/library/papers/24563333PubMed
1735185350Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines.Clin Med Insights Endocrinol Diabetes2022https://conductscience.org/library/papers/35185350PubMed
1815901787Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.J Neurosci2005https://conductscience.org/library/papers/15901787PubMed
1921349175TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes.BMC Med Genet2011https://conductscience.org/library/papers/21349175PubMed
2024559921The calcium-sensing receptor and β-cell function.Vitam Horm2014https://conductscience.org/library/papers/24559921PubMed

See all 58 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42978695Diabesity: an old term, a modern challenge - multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes.J Pharm Pharm Sci2026https://conductscience.org/library/papers/42978695PubMed
42882529
Targeting Gut Microbiota, Inflammation, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: Therapeutic Strategies and the Emerging Role of Time-Restricted Feeding.
Cells2026https://conductscience.org/library/papers/42882529PubMed
42346643Bridging Ancestry-Stratified Bias in Pharmacogenomics AI: Toward Metabolomics-Inclusive Multi-Omics Precision Medicine.J Pers Med2026https://conductscience.org/library/papers/42346643PubMed
41987878Pharmacological treatment patterns, factors associated with glycemic control, and renal function parameters in a real-world cohort of Hispanic adults with type 2 diabetes.Biomed Rep2026https://conductscience.org/library/papers/41987878PubMed
41900041Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes.Molecules2026https://conductscience.org/library/papers/41900041PubMed
41872653Implications of Genetic Elements on Type 2 Diabetes Mellitus Pathogenesis and Management.Endocrinol Diabetes Metab2026https://conductscience.org/library/papers/41872653PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39355646

GET https://conductscience.org/api/papers/v1/39355646/references?page=2